Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 Nov;45(11):1018–1022. doi: 10.1136/jcp.45.11.1018

CD43 expression in B cell lymphoma.

J Treasure 1, A Lane 1, D B Jones 1, D H Wright 1
PMCID: PMC495037  PMID: 1280654

Abstract

AIMS: To determine the expression of CD43 in frozen sections in a range of B cell lymphomas. METHODS: The monoclonal antibody WR14, clustered provisionally in the Fourth Leucocyte Typing Workshop as a CD43 reagent, was investigated by epitope blocking studies on formalin fixed reactive lymph node tissue, using the established CD43 antibody MT1, to validate its use as a CD43 reagent. CD43 expression was studied in 131 immunophenotypically defined B cell lymphomas, including lymphocytic lymphoma (Lc, n = 13), centrocytic lymphoma (Cc, n = 14), and a range of follicle centre cell lymphomas (FCC) including centroblastic/centrocytic follicular (CbCcF, n = 48), centroblastic diffuse (CbD, n = 39), centroblastic/centrocytic diffuse (CbCcD, n = 4), centroblastic follicular and diffuse (Cb FD, n = 3) and centroblastic/centrocytic follicular and diffuse (CbCc FD, n = 1). Nine lymphomas of mucosa associated lymphoid tissue (MALT) were also examined. RESULTS: Epitope blocking studies showed that WR14 is a CD43 reagent that binds to an epitope identical with or close to that recognised by MT1. Eleven of 13 (84%) cases of Lc and 11 of 14 (78%) cases of Cc expressed CD43; 87 of 95 (91%) cases of FCC did not. All eight low grade lymphomas of MALT were negative. One high grade lymphoma, transformed from a low grade MALT lymphoma, was positive for CD43. The expression of CD43 by tumours of B cell lineage was associated with the expression of CD5 (p < 0.001) although either antigen could occasionally be found in the absence of the other. CONCLUSION: CD43 reagents can be used in conjunction with CD5 antibodies for the immunophenotypic discrimination of follicle centre cell lymphomas from non-follicle centre cell lymphomas.

Full text

PDF
1018

Images in this article

1019Image
on p.1019
1020Image
on p.1020
1021Image
on p.1021

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beverley P. C., Callard R. E. Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol. 1981 Apr;11(4):329–334. doi: 10.1002/eji.1830110412. [DOI] [PubMed] [Google Scholar]
  2. Burns B. F., Warnke R. A., Doggett R. S., Rouse R. V. Expression of a T-cell antigen (Leu-1) by B-cell lymphomas. Am J Pathol. 1983 Nov;113(2):165–171. [PMC free article] [PubMed] [Google Scholar]
  3. Dobson C. M., Myskow M. W., Krajewski A. S., Carpenter F. H., Horne C. H. Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies. J Pathol. 1987 Nov;153(3):203–212. doi: 10.1002/path.1711530304. [DOI] [PubMed] [Google Scholar]
  4. Hall P. A., D'Ardenne A. J., Butler M. G., Habeshaw J. R., Stansfeld A. G. New marker of B lymphocytes, MB2: comparison with other lymphocyte subset markers active in conventionally processed tissue sections. J Clin Pathol. 1987 Feb;40(2):151–156. doi: 10.1136/jcp.40.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hall P. A., d'Ardenne A. J., Stansfeld A. G. Paraffin section immunohistochemistry. I. Non-Hodgkin's lymphoma. Histopathology. 1988 Aug;13(2):149–160. doi: 10.1111/j.1365-2559.1988.tb02020.x. [DOI] [PubMed] [Google Scholar]
  6. Hogg N., Ross G. D., Jones D. B., Slusarenko M., Walport M. J., Lachmann P. J. Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1). Eur J Immunol. 1984 Mar;14(3):236–243. doi: 10.1002/eji.1830140307. [DOI] [PubMed] [Google Scholar]
  7. Knowles D. M., 2nd, Halper J. P., Azzo W., Wang C. Y. Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers. Cancer. 1983 Oct 15;52(8):1369–1377. doi: 10.1002/1097-0142(19831015)52:8<1369::aid-cncr2820520806>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  8. Moore K., Cooper S. A., Jones D. B. Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy. J Pathol. 1987 May;152(1):13–21. doi: 10.1002/path.1711520103. [DOI] [PubMed] [Google Scholar]
  9. Moore K., Nesbitt A. M. Identification and isolation of OKT4+ suppressor cells with the monoclonal antibody WR16. Immunology. 1986 Aug;58(4):659–664. [PMC free article] [PubMed] [Google Scholar]
  10. Ng C. S., Chan J. K., Hui P. K., Lo S. T. Monoclonal antibodies reactive with normal and neoplastic T cells in paraffin sections. Hum Pathol. 1988 Mar;19(3):295–303. doi: 10.1016/s0046-8177(88)80522-7. [DOI] [PubMed] [Google Scholar]
  11. Ngan B. Y., Picker L. J., Medeiros L. J., Warnke R. A. Immunophenotypic diagnosis of non-Hodgkin's lymphoma in paraffin sections. Co-expression of L60 (Leu-22) and L26 antigens correlates with malignant histologic findings. Am J Clin Pathol. 1989 May;91(5):579–583. doi: 10.1093/ajcp/91.5.579. [DOI] [PubMed] [Google Scholar]
  12. Norton A. J., Isaacson P. G. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue. Am J Pathol. 1987 Aug;128(2):225–240. [PMC free article] [PubMed] [Google Scholar]
  13. Norton A. J., Isaacson P. G. Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded tissues: II. Profiles of reactivity in the various tumour types. Histopathology. 1989 Jun;14(6):557–579. doi: 10.1111/j.1365-2559.1989.tb02198.x. [DOI] [PubMed] [Google Scholar]
  14. Picker L. J., Weiss L. M., Medeiros L. J., Wood G. S., Warnke R. A. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol. 1987 Jul;128(1):181–201. [PMC free article] [PubMed] [Google Scholar]
  15. Poppema S., Hollema H., Visser L., Vos H. Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. Am J Pathol. 1987 Jun;127(3):418–429. [PMC free article] [PubMed] [Google Scholar]
  16. Reinherz E. L., Kung P. C., Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588–1592. doi: 10.1073/pnas.77.3.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schwarting R., Stein H., Wang C. Y. The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. Blood. 1985 Apr;65(4):974–983. [PubMed] [Google Scholar]
  18. Spencer J., Finn T., Pulford K. A., Mason D. Y., Isaacson P. G. The human gut contains a novel population of B lymphocytes which resemble marginal zone cells. Clin Exp Immunol. 1985 Dec;62(3):607–612. [PMC free article] [PubMed] [Google Scholar]
  19. Stross W. P., Warnke R. A., Flavell D. J., Flavell S. U., Simmons D., Gatter K. C., Mason D. Y. Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen. J Clin Pathol. 1989 Sep;42(9):953–961. doi: 10.1136/jcp.42.9.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. West K. P., Warford A., Fray L., Allen M., Campbell A. C., Lauder I. The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections. J Pathol. 1986 Oct;150(2):89–101. doi: 10.1002/path.1711500203. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES